Kevin Anderson joined the Roche Partnering organization in 2011 as Director of Business Development in Infectious Diseases.  Prior to Roche, Dr. Anderson served as CEO for CNS biotech startup, Kinexis, and co-founded Chimerix, a public company developing antiviral drugs.  Kevin also served as Director of Infectious Diseases Research at Isis Pharmaceuticals after beginning his career as a research scientist at Genentech.  He holds a PhD in Molecular Biology and Biochemistry and an MBA from UC Irvine.